Abdel-Meguid; Sherin Salaheldin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Abdel-Meguid; Sherin Salaheldin.The latest application filed is for "anti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) nano-formulation of compounds and methods of using the same".

Company Profile

5.4.7

Abdel-Meguid; Sherin Salaheldin - Exton PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-proprotein Convertase Subtilisin Kexin Type 9 (anti-pcsk9) Nano-formulation Of Compounds And Methods Of Using The Same App 20220031665 - Mousa; Shaker A. ; et al.	2022-02-03
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases Grant 10,947,220 - Abdel-Meguid , et al. March 16, 2	2021-03-16
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases Grant 10,899,748 - Abdel-Meguid , et al. January 26, 2	2021-01-26
Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or App 20200262822 - Abdel-Meguid; Sherin Salaheldin ; et al.	2020-08-20
Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or App 20190270729 - Abdel-Meguid; Sherin Salaheldin ; et al.	2019-09-05
Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases Grant 10,131,637 - Abdel-Meguid , et al. November 20, 2	2018-11-20
Anti-pcsk9 Compounds And Methods For The Treatment And/or Prevention Of Cardiovascular Diseases App 20180079730 - Abdel-Meguid; Sherin Salaheldin ; et al.	2018-03-22
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases Grant 9,682,085 - Abdel-Meguid , et al. June 20, 2	2017-06-20
Anti-proprotein Convertase Subtilisin Kexin Type 9 (anti-pcsk9) Compounds And Methods Of Using The Same In The Treatment And/or Prevention Of Cardiovascular Diseases App 20160256467 - Abdel-Meguid; Sherin Salaheldin ; et al.	2016-09-08
Anti-proprotein Convertase Subtilisin Kexin Type 9 (anti-pcsk9) Compounds And Methods Of Using The Same In The Treatemnt And/or Prevention Of Cardiovascular Diseases App 20150374710 - Abdel-Meguid; Sherin Salaheldin ; et al.	2015-12-31
Anti-pcsk9 Compounds And Methods For The Treatment And/or Prevention Of Cardiovascular Diseases App 20150376139 - Abdel-Meguid; Sherin Salaheldin ; et al.	2015-12-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.